The burden of cardiovascular diseases (CVDs) among smokers is profoundly evident, cigarette smoking, a leading preventable ...

Teleflex Incorporated (NYSE: TFX) has announced its agreement to acquire BIOTRONIK’s Vascular Intervention business in a ...

Singh, A. , Sinha, R. , Saran, M. , Kazmi, D. , Gupta, H. and Seth, G. (2025) Efficacy and Safety of Dual Antiplatelet Therapy in High-Risk, Post-Percutaneous Coronary Intervention Patients beyond One ...

Implantable Drug Eluting Devices Market. The Global Implantable Drug Eluting Devices Market was valued at approximately USD ...

Teleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026 ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Teleflex Incorporated announced it has entered into a definitive agreement to acquire substantially all of the Vascular ...

Medical devices provider, Teleflex (NYSE:TFX) said on Thursday that it will acquire all of the vascular intervention business ...

Teleflex (TFX) announced it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of ...

Since the advent of drug-eluting stents, there has been a debate in the intervention community over how long dual ...

Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...

It is driven by advancements in material science and miniaturisation. The global balloon catheters market, valued at $4.4b in ...